Logo image of EM

SMART SHARE GLOBAL LTD - ADR (EM) Stock Fundamental Analysis

NASDAQ:EM - Nasdaq - US83193E1029 - ADR - Currency: USD

1.14  0 (0%)

Fundamental Rating

3

EM gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 120 industry peers in the Specialty Retail industry. The financial health of EM is average, but there are quite some concerns on its profitability. EM does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

In the past year EM was profitable.
EM had negative earnings in 4 of the past 5 years.
EM had a positive operating cash flow in 4 of the past 5 years.
EM Yearly Net Income VS EBIT VS OCF VS FCFEM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 0 -1B -2B -3B -4B

1.2 Ratios

EM's Return On Assets of 1.98% is in line compared to the rest of the industry. EM outperforms 55.56% of its industry peers.
EM has a Return On Equity of 3.19%. This is comparable to the rest of the industry: EM outperforms 58.12% of its industry peers.
Industry RankSector Rank
ROA 1.98%
ROE 3.19%
ROIC N/A
ROA(3y)-42.45%
ROA(5y)-50.56%
ROE(3y)-59.05%
ROE(5y)-78.52%
ROIC(3y)N/A
ROIC(5y)N/A
EM Yearly ROA, ROE, ROICEM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 0 -50 -100 -150

1.3 Margins

EM has a Profit Margin of 2.96%. This is in the better half of the industry: EM outperforms 65.81% of its industry peers.
Looking at the Gross Margin, with a value of 59.12%, EM belongs to the top of the industry, outperforming 88.03% of the companies in the same industry.
In the last couple of years the Gross Margin of EM has declined.
Industry RankSector Rank
OM N/A
PM (TTM) 2.96%
GM 59.12%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-11.28%
GM growth 5YN/A
EM Yearly Profit, Operating, Gross MarginsEM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 0 50 -50 -100

More info and screens

5

2. Health

2.1 Basic Checks

EM does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, EM has about the same amount of shares outstanding.
Compared to 1 year ago, EM has an improved debt to assets ratio.
EM Yearly Shares OutstandingEM Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 50M 100M 150M 200M 250M
EM Yearly Total Debt VS Total AssetsEM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 1B 2B 3B 4B

2.2 Solvency

EM has an Altman-Z score of -0.78. This is a bad value and indicates that EM is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -0.78, EM is doing worse than 86.32% of the companies in the same industry.
EM has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.00, EM is in the better half of the industry, outperforming 76.07% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -0.78
ROIC/WACCN/A
WACC8.81%
EM Yearly LT Debt VS Equity VS FCFEM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 0 1B 2B 3B

2.3 Liquidity

A Current Ratio of 2.74 indicates that EM has no problem at all paying its short term obligations.
EM has a better Current ratio (2.74) than 91.45% of its industry peers.
EM has a Quick Ratio of 2.67. This indicates that EM is financially healthy and has no problem in meeting its short term obligations.
EM's Quick ratio of 2.67 is amongst the best of the industry. EM outperforms 95.73% of its industry peers.
Industry RankSector Rank
Current Ratio 2.74
Quick Ratio 2.67
EM Yearly Current Assets VS Current LiabilitesEM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 1B 2B 3B 4B

More info and screens

2

3. Growth

3.1 Past

The earnings per share for EM have decreased strongly by -94.27% in the last year.
Looking at the last year, EM shows a very strong growth in Revenue. The Revenue has grown by 27.62%.
EPS 1Y (TTM)-94.27%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%400%
Revenue 1Y (TTM)27.62%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-55.3%

3.2 Future

Based on estimates for the next years, EM will show a quite strong growth in Earnings Per Share. The EPS will grow by 15.58% on average per year.
The Revenue is expected to decrease by -10.87% on average over the next years. This is quite bad
EPS Next Y-560.47%
EPS Next 2Y9.25%
EPS Next 3Y2.5%
EPS Next 5Y15.58%
Revenue Next Year-17.79%
Revenue Next 2Y-8.11%
Revenue Next 3Y-20.74%
Revenue Next 5Y-10.87%

3.3 Evolution

EM Yearly Revenue VS EstimatesEM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 1B 2B 3B
EM Yearly EPS VS EstimatesEM Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 0 0.5 -0.5 -1 -1.5

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 22.80, the valuation of EM can be described as rather expensive.
Based on the Price/Earnings ratio, EM is valued a bit cheaper than the industry average as 63.25% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 30.30. EM is valued slightly cheaper when compared to this.
EM is valuated rather expensively with a Price/Forward Earnings ratio of 20.39.
The rest of the industry has a similar Price/Forward Earnings ratio as EM.
EM is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 23.06, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 22.8
Fwd PE 20.39
EM Price Earnings VS Forward Price EarningsEM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
EM Per share dataEM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y9.25%
EPS Next 3Y2.5%

More info and screens

1

5. Dividend

5.1 Amount

EM has a yearly dividend return of 0.72%, which is pretty low.
Compared to an average industry Dividend Yield of 4.03, EM pays a bit more dividend than its industry peers.
With a Dividend Yield of 0.72, EM pays less dividend than the S&P500 average, which is at 2.29.
Industry RankSector Rank
Dividend Yield 0.72%

5.2 History

EM does not have a reliable dividend history as it only pays dividend since a couple or years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
EM Yearly Dividends per shareEM Yearly Dividends per shareYearly Dividends per share 2024 0.01 0.01 0.02 0.02 0.03

5.3 Sustainability

DPN/A
EPS Next 2Y9.25%
EPS Next 3Y2.5%
EM Yearly Income VS Free CF VS DividendEM Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2019 2020 2021 2022 2023 0 -1B -2B -3B -4B

More info and screens

SMART SHARE GLOBAL LTD - ADR

NASDAQ:EM (2/20/2025, 8:13:18 PM)

1.14

0 (0%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)08-22 2024-08-22/bmo
Earnings (Next)N/A N/A
Inst Owners2.2%
Inst Owner Change-0.77%
Ins Owners2.19%
Ins Owner ChangeN/A
Market Cap295.92M
Analysts86
Price Target1.89 (65.79%)
Short Float %0.02%
Short Ratio0.02
Dividend
Industry RankSector Rank
Dividend Yield 0.72%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.34%
Min Revenue beat(2)-7.88%
Max Revenue beat(2)8.56%
Revenue beat(4)1
Avg Revenue beat(4)-2.33%
Min Revenue beat(4)-7.88%
Max Revenue beat(4)8.56%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 22.8
Fwd PE 20.39
P/S 0.73
P/FCF N/A
P/OCF N/A
P/B 0.78
P/tB 0.78
EV/EBITDA N/A
EPS(TTM)0.05
EY4.39%
EPS(NY)0.06
Fwd EY4.9%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS1.57
BVpS1.46
TBVpS1.46
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.98%
ROE 3.19%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 2.96%
GM 59.12%
FCFM N/A
ROA(3y)-42.45%
ROA(5y)-50.56%
ROE(3y)-59.05%
ROE(5y)-78.52%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-11.28%
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.67
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.74
Quick Ratio 2.67
Altman-Z -0.78
F-ScoreN/A
WACC8.81%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-94.27%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%400%
EPS Next Y-560.47%
EPS Next 2Y9.25%
EPS Next 3Y2.5%
EPS Next 5Y15.58%
Revenue 1Y (TTM)27.62%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-55.3%
Revenue Next Year-17.79%
Revenue Next 2Y-8.11%
Revenue Next 3Y-20.74%
Revenue Next 5Y-10.87%
EBIT growth 1Y99.83%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year527.66%
EBIT Next 3Y131.14%
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A